Loading...
Please wait, while we are loading the content...
Rivaroxaban（Xarelto®）－預防心房顫動相關中風的新藥
| Content Provider | Semantic Scholar |
|---|---|
| Author | 陳昭姿 |
| Copyright Year | 2012 |
| Abstract | Rivaroxaban (Xarelto) 1 What is rivaroxaban (Xarelto)? • Rivaroxaban is also called Xarelto® • Rivaroxaban is used to reduce the risk of blood clots and stroke in people with an abnormal heart rhythm known as atrial fibrillation, in people who have had a blood clot, or in people who have undergone orthopedic surgery. o Blood clots can block a blood vessel cutting off blood supply to the area. o Rarely, clots can break into pieces and travel in the blood stream, lodging in the heart (causing a heart attack), the lungs (causing a pulmonary embolus), or in the brain (causing a stroke). • If you were previously on warfarin and you are starting rivaroxaban, do not continue taking warfarin. Rivaroxaban replaces warfarin. |
| Starting Page | 704 |
| Ending Page | 707 |
| Page Count | 4 |
| File Format | PDF HTM / HTML |
| DOI | 10.29941/MT.201209.0015 |
| Alternate Webpage(s) | http://www.med.umich.edu/1libr/AntiCoag/Rivaroxaban.pdf |
| Alternate Webpage(s) | https://www.orlando.va.gov/patients/RivaroxabanPatientEd.pdf |
| Alternate Webpage(s) | https://www.indianapolis.va.gov/docs/rivaroxaban_FAQ_March_2015.pdf |
| Alternate Webpage(s) | https://doi.org/10.29941/MT.201209.0015 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
